[1]
Y. Kun, J. Wu, and S. Chen, “Effects of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) targeted combined chemotherapy on immune function, tumor markers and oxidative stress in patients with stage IV lung adenocarcinoma”, Pak J Med Sci, vol. 39, no. 3, Mar. 2023.